Join us at
Probiota Europe 2025

February 5-7, 2025
Copenaghen
(Bella Center)
Probiota Europe, the leading Microbiome industry event, uniting the realms of microbiome science and business
ibSium® - S. cerevisiae CNCM I-3856
ibSium® (Saccharomyces cerevisiae CNCM I-3856) is a patented probiotic yeast registered as Saccharomyces cerevisiae CNCM I-3856. Recognized as a reference probiotic strain, ibSium® has demonstrated its effectiveness in several rigorous clinical studies, showing that this yeast can significantly relieve gastrointestinal symptoms and improve overall quality of life.
Discover our market leadership human health
We have been building our expertise and market leadership in five key market segments, offering a portfolio of solutions that improve health and wellbeing throughout the entire body.
- Wellness & Immune Health: Immunity, Daily Nutrition, Cardiovascular Health, Beauty, and General Wellbeing
- Digestion & Gut Health: Microbiome Balance, Digestive Comfort, Liver Health Support
- Mobility & Joint Health: Bone Health, Joint Health, Muscle Health, and Sports Nutrition
- Reproduction & Women’s Health: Vaginal Care, Urinary Health, Fertility, Pregnancy, and Menopause
- Mood & Cognitive Health: Mood Health, Cognition, and Stress & Anxiety
Related articles

- MenaQ7®
- Mobility & Joint
- News
- Jun 02, 2025
Supplementation with Menaquinone-7 (as MenaQ7®) Slows the Progression of Coronary Artery Calcification
The first results from the VitaK-CAC Trial, “Menaquinone-7 Slows Down Progression of Coronary Artery...

- Digestion & Gut
- ibSium®
- News
- May 29, 2025
Natural Probiotic Yeast Support on World Digestive Health Day
Each year on May 29, World Digestive Health Day raises global awareness about the...

- Lynside® Nutritional Yeasts
- News
- Wellness & Immune
- May 27, 2025
Infodemiology Offers a Fresh Lens on Nutritional Yeast
Haven’t you ever wondered what consumers think about yeast? Infodemiology, an innovative social media...